1. Home
  2. IFF vs MEDP Comparison

IFF vs MEDP Comparison

Compare IFF & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$72.36

Market Cap

18.1B

Sector

Industrials

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$490.89

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
MEDP
Founded
1833
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
14.9B
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
IFF
MEDP
Price
$72.36
$490.89
Analyst Decision
Strong Buy
Hold
Analyst Count
13
13
Target Price
$91.33
$498.25
AVG Volume (30 Days)
1.5M
271.9K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
2.19%
N/A
EPS Growth
N/A
20.98
EPS
N/A
15.28
Revenue
N/A
N/A
Revenue This Year
N/A
$13.19
Revenue Next Year
$2.93
$7.75
P/E Ratio
N/A
$32.79
Revenue Growth
N/A
N/A
52 Week Low
$59.14
$250.05
52 Week High
$84.45
$628.92

Technical Indicators

Market Signals
Indicator
IFF
MEDP
Relative Strength Index (RSI) 50.38 55.24
Support Level $60.98 $489.09
Resistance Level $74.51 $501.30
Average True Range (ATR) 1.98 16.54
MACD 0.48 5.43
Stochastic Oscillator 76.91 57.30

Price Performance

Historical Comparison
IFF
MEDP

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest this business in the future.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: